Energy Fuels Inc. Announces Q2 2025 Financial Results Conference Call

Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR), a prominent U.S. producer of uranium, rare earth elements, and critical minerals, has scheduled a conference call...

Jul 24, 2025 | Press Release

Mullen Automotive Inc. Rebrands to Bollinger Innovations, Signaling Strategic Shift

Mullen Automotive Inc. (NASDAQ: MULN), a prominent electric vehicle manufacturer, is set to undergo a significant rebranding, changing its name to Bollinger Innovations, Inc. starting...

Jul 24, 2025 | Press Release

Candel Therapeutics’ CAN-2409 Receives European Orphan Designation for Pancreatic Cancer Treatment

Candel Therapeutics, Inc., a clinical-stage biopharmaceutical company, has announced that the European Medicines Agency (EMA) has granted Orphan Designation for its drug CAN-2409, aimed at...

Jul 24, 2025 | Press Release

Meta Opts Out of EU’s Voluntary AI Code of Practice Ahead of New Regulations

Meta has announced it will not be signing the European Union’s voluntary code of practice related to the forthcoming AI Act, a move that underscores...

Jul 24, 2025 | Press Release

BitFrontier Capital Holdings, Inc. Announces Strategic Turnaround Under New CEO Dr. Jordan P. Balencic

BitFrontier Capital Holdings, Inc. (OTC: BFCH), a company previously focused on cryptocurrency mining and hosting services, has announced a significant shift in its business strategy...

Jul 24, 2025 | Press Release

Hero Response Expands Its Restoration Services to Ontario with Two New Locations

Hero Response, a nationally recognized full-service restoration leader, has announced the expansion of its operations to include two new locations in Ontario. This move underscores...

Jul 24, 2025 | Press Release

ABVC BioPharma and OncoX BioPharma Strengthen Oncology Collaboration with $100,000 Milestone Payment

ABVC BioPharma, Inc., a clinical-stage biopharmaceutical company, has announced the receipt of a $100,000 milestone payment from OncoX BioPharma, Inc., marking a significant step in...

Jul 24, 2025 | Press Release

GeoVax Revises Gedeptin® Clinical Strategy Following KEYNOTE-689 Trial Results

GeoVax Labs, Inc. has announced a significant update to its Gedeptin® clinical development program, shifting focus towards evaluating Gedeptin as a neoadjuvant therapy in combination...

Jul 24, 2025 | Press Release

SMILE-FX® Recognized as a Pioneer in Caribbean-Owned Orthodontic Innovation in South Florida

SMILE-FX®, a minority-owned orthodontic studio, has been celebrated by the City of Miramar and Commissioner Avril Cherasard for its significant contributions to healthcare innovation and...

Jul 24, 2025 | Press Release